ACell, Inc. offers the next generation of regenerative medicine through the development and commercialization of unique extracellular matrix (ECM) products to repair and remodel damaged tissues in a broad range of applications.

ACell's patented ECM devices address important clinical needs, providing safe, effective, economical and therapeutic outcomes to the wound care and surgical communities. These devices, trademarked as MatriStem, are appropriate for acute wounds, chronic wounds and various surgical procedures. All MatriStem devices are made in the USA.